The transition into production and sales is proving a pivotal moment for Cylite, as we embark on a crucial scale-up to bring our technology to the world. We were grateful to be featured in Insight July 2022, in which the team took a look at Cylite’s growth and scale up activities.
How Hyperparallel technology is transforming clini...
With its ability to overcome constraints related to eye motion artefacts, its true volumetric imaging capabilities, and its micron-level accuracy, HP-…Read more
New Cylite CEO eyes off the $4.8 billion global ey...
Kylee Hall, a proven leader in the Australasian Ophthalmic Industry, has taken over as Cylite’s CEO from renowned scientist Dr Steve Frisken. Ms Hall…Read more
Cylite supporting Australian business
Two Australian companies working together to create beautifully crafted products. Milton Ashby have worked with the team at Cylite to create a b…Read more